Information on Controlled-Release Tablets of Methylphenidate – Phentermin375.com

Generic Name and Brand Names

The generic name of this medicine is Methylphenidate Controlled-Release Tablets, also known as meth-il-FEN-i-date. It is available under the brand names Methylin ER and Ritalin SR. This medicine belongs to the drug class of CNS stimulants.

Warning

It is important to note that this medicine has a risk of abuse and misuse. It should only be used as directed by a doctor. Patients should inform their doctor if they have a history of drug or alcohol abuse or addiction.

Uses of Methylphenidate Controlled-Release Tablets

This medicine is primarily used to treat attention deficit problems with hyperactivity and narcolepsy. However, it may also be prescribed for other reasons, as determined by a doctor.

What to Tell Your Doctor Before Taking Methylphenidate Controlled-Release Tablets

Prior to taking this medicine, patients should inform their doctor if they have an allergy to methylphenidate or any other part of the medicine. They should also disclose any health problems they have, including glaucoma, agitation, anxiety, overactive thyroid, blood vessel disease, high blood pressure, heart structure problems or other heart problems, Tourette’s syndrome or tics, or if they have ever had a stroke. Patients should also inform their doctor if they have taken certain drugs for depression or Parkinson’s disease in the last 14 days, or if they are taking any other medications.

What to Know While Taking Methylphenidate Controlled-Release Tablets

Patients taking this medicine should inform all healthcare providers, including doctors, nurses, pharmacists, and dentists. They should avoid driving or performing tasks that require alertness until they know how the medicine affects them. Patients should also be aware of the risk of heart attacks, strokes, and sudden deaths, which have occurred in adults taking this medicine. Patients should contact their doctor immediately if they experience any symptoms of these conditions. Additionally, patients may need to have some heart tests before starting this medicine.

How to Take Methylphenidate Controlled-Release Tablets

Patients should take this medicine as directed by their doctor, and should not chew, break, or crush the tablets. If patients have been taking this medicine for a long time or at high doses, it may not work as well and they may need higher doses to achieve the same effect. Patients should not take more than the prescribed dose. Additionally, patients should limit their use of caffeine and avoid drinking alcohol while taking this medicine.

Possible Side Effects

Like all medicines, Methylphenidate Controlled-Release Tablets may cause side effects. Patients should contact their doctor if they experience any serious side effects, such as signs of an allergic reaction, high blood pressure, liver problems, joint pain, seizures, shakiness, trouble controlling body movements, sweating, restlessness, numbness or pain in the hands or feet, muscle pain or weakness, changes in sex interest, or painful erections lasting longer than four hours. Patients may also experience minor side effects such as dizziness, sleepiness, dry mouth, headache, upset stomach or vomiting, weight loss, nervousness or excitability, loss of appetite, trouble sleeping, stomach pain or heartburn, or nose or throat irritation.

How to Store and Dispose of Methylphenidate Controlled-Release Tablets

Patients should store this medicine at room temperature and protect it from light. They should keep it in a dry place and out of the reach of children and pets. Patients should dispose of any unused or expired medicine properly, according to their pharmacist’s instructions.

Consumer Information Use and Disclaimer

If patients’ symptoms or health problems do not improve or worsen, they should contact their doctor. Patients should not share their medicine with others or take anyone else’s medicine. Patients should read the medication guide provided with this medicine and contact their doctor, pharmacist, or other healthcare provider with any questions. If patients suspect an overdose, they should contact their poison control center or seek medical care immediately.